Using a knowledge translation program to facilitate guideline- and evidence-based patient management: the PAH-QuERI Extension Program.

Vallerie V McLaughlinRichard N ChannickKarimah S Bell LynumRonald J OudizMona SelejVictor F TapsonLewis J Rubin

Published in: Pulmonary circulation (2022)

The Pulmonary Arterial Hypertension-Quality Enhancement Research Initiative Extension Program was designed to support physicians' adherence to pulmonary arterial hypertension (PAH) guidelines. Guidelines were followed in >95% of patients with functional class (FC) II/III, but for only 28.6% of FC IV patients (Month 36). Low adherence was driven by FC IV patients' preference to avoid parenteral treatment.

Keyphrases

pulmonary arterial hypertension
quality improvement
end stage renal disease
pulmonary artery
pulmonary hypertension
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
primary care
adipose tissue
type diabetes
coronary artery
glycemic control
weight loss